Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Glioblastoma
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 80 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02685605
Collaborators
  • Carl Zeiss Meditec AG
  • University of California, Los Angeles
Investigators
Principal Investigator: Frank A. Giordano, MD Department of Radiation Oncology, University Hospital Bonn, Univeristy of Bonn, Bonn, Germany Principal Investigator: Kevin Petrecca, MD Department of Neurosurgery, Montréal Neurological, Institute and Hospital, Montréal, Canada